Halozyme (HALO) EBITDA margin US GAAP (year values)

2020 2021 2022 2022 2023   LTM ?
EBITDA margin, % ? 53.9% 62.2% 47.8% 47.1% 50.9%   53.4%
Changes by years, y/y, % +88pp +8pp -14pp -1pp +4pp    

Halozyme. EBITDA margin, %

Halozyme. EBITDA margin, changes, pp

Halozyme (HALO) EBITDA margin US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
EBITDA margin, % ? 44.2% 52.1% 50.3% 52.9% 59.1%   53.4%
Changes by years, y/y, % -21pp +21pp -4pp +9pp +15pp    
Changes by quarters, q/q, % +1pp +8pp -2pp +3pp +6pp    

Halozyme. EBITDA margin, %

Halozyme. EBITDA margin, changes, pp

Halozyme. EBITDA margin, changes, pp